This study investigates the effects of an investigational medication given once a week to people with Hemophilia A who have joint swelling known as synovial hypertrophy. Participants in this study will receive the investigational medication once a week for about 12 months. During the study, doctors will monitor the participants' …
This study investigates the effects of switching from emicizumab to an investigational medication for individuals with severe hemophilia A. The purpose of this study is to understand the safety and tolerability of the investigational medication after participants transition from their current preventive treatment.Participants will undergo a screening period followed by …
This study investigates the impact of starting prophylaxis on physical activity and goal attainment in individuals with hemophilia A. This observational study will collect data from participants in the US and Japan who are newly starting prophylaxis treatment.Participants will be required to use a physical activity tracker compatible with their …
